BridgeBio Pharma (2CL.STU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.72
-0.67
-0.62
-0.58

Details

Expected EPS
-0.5787642578900001
Actual EPS
-0.7162428
Surprise EPS
-0.14
Surprise Percent
+23.75%

Description

BridgeBio Pharma (2CL.STU) has reported earnings of -0.7162428 per share for Q2 2026.

0 Comments

Share your thoughts